Pittenger & Anderson Inc’s iShares Biotechnology ETF IBB Stock Holding History

Pittenger & Anderson Inc’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$200K	Hold	1,050	–	–	0.01%	234
2026 Q1	$177K	Hold	1,050	–	–	0.01%	237
2025 Q4	$177K	Hold	1,050	–	–	0.01%	236
2025 Q3	$152K	Hold	1,050	–	–	0.01%	240
2025 Q2	$133K	Hold	1,050	–	–	﹤0.01%	237
2025 Q1	$134K	Hold	1,050	–	–	﹤0.01%	230
2024 Q4	$139K	Hold	1,050	–	–	0.01%	238
2024 Q3	$153K	Hold	1,050	–	–	0.01%	247
2024 Q2	$144K	Hold	1,050	–	–	0.01%	241
2024 Q1	$144K	Hold	1,050	–	–	0.01%	242
2023 Q4	$143K	Hold	1,050	–	–	0.01%	240
2023 Q3	$128K	Sell	1,050 -108	-9%	-$13.7K	0.01%	220
2023 Q2	$147K	Buy	1,158 +108	+10%	+$14K	0.01%	220
2023 Q1	$136K	Hold	1,050	–	–	0.01%	227
2022 Q4	$138K	Sell	1,050 -127	-11%	-$16.4K	0.01%	224
2022 Q3	$138K	Hold	1,177	–	–	0.01%	216
2022 Q2	$138K	Sell	1,177 -1,156	-50%	-$137K	0.01%	226
2022 Q1	$304K	Sell	2,333 -721	-24%	-$93.9K	0.01%	185
2021 Q4	$466K	Sell	3,054 -421	-12%	-$65.2K	0.02%	170
2021 Q3	$562K	Buy	3,475 +79	+2%	+$13.3K	0.03%	160
2021 Q2	$556K	Sell	3,396 -262	-7%	-$40.4K	0.03%	157
2021 Q1	$551K	Buy	3,658 +267	+8%	+$42.4K	0.03%	162
2020 Q4	$514K	Buy	3,391 +100	+3%	+$14.3K	0.03%	168
2020 Q3	$446K	Buy	3,291 +990	+43%	+$134K	0.03%	172
2020 Q2	$315K	Buy	2,301 +911	+66%	+$116K	0.02%	181
2020 Q1	$150K	Buy	1,390 +250	+22%	+$28.8K	0.01%	197
2019 Q4	$137K	Hold	1,140	–	–	0.01%	232
2019 Q3	$113K	Hold	1,140	–	–	0.01%	237
2019 Q2	$124K	Hold	1,140	–	–	0.01%	228
2019 Q1	$127K	Hold	1,140	–	–	0.01%	223
2018 Q4	$110K	Hold	1,140	–	–	0.01%	226
2018 Q3	$139K	Hold	1,140	–	–	0.01%	228
2018 Q2	$125K	Sell	1,140 -300	-21%	-$32.1K	0.01%	228
2018 Q1	$154K	Hold	1,440	–	–	0.01%	229
2017 Q4	$154K	Sell	1,440 -60	-4%	-$6.41K	0.01%	225
2017 Q3	$167K	Hold	1,500	–	–	0.02%	217
2017 Q2	$155K	Hold	1,500	–	–	0.01%	218
2017 Q1	$147K	Hold	1,500	–	–	0.01%	221
2016 Q4	$133K	Hold	1,500	–	–	0.01%	235
2016 Q3	$145K	Hold	1,500	–	–	0.02%	226
2016 Q2	$129K	Sell	1,500 -105	-7%	-$9.42K	0.01%	235
2016 Q1	$140K	Sell	1,605 -30	-2%	-$2.68K	0.02%	247
2015 Q4	$184K	Sell	1,635 -111	-6%	-$12K	0.02%	246
2015 Q3	$177K	Hold	1,746	–	–	0.02%	259
2015 Q2	$215K	Buy	1,746 +21	+1%	+$2.51K	0.03%	256
2015 Q1	$197K	Sell	1,725 -510	-23%	-$56.3K	0.03%	256
2014 Q4	$226K	Sell	2,235 -30	-1%	-$2.92K	0.03%	238
2014 Q3	$207K	Hold	2,265	–	–	0.03%	232
2014 Q2	$194K	Sell	2,265 -660	-23%	-$52K	0.03%	243
2014 Q1	$230K	Sell	2,925 -3,330	-53%	-$277K	0.03%	277
2013 Q4	$473K	Buy	6,255 +2,820	+82%	+$200K	0.07%	224
2013 Q3	$240K	Buy	+3,435	New	+$225K	0.04%	256

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Pittenger & Anderson Inc's IBB Position: Q2 2026 in Review

Pittenger & Anderson Inc held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,050 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #234.

Pittenger & Anderson Inc first reported a position in IBB in Q3 2013 and has held it in 52 quarters since. The position peaked at $562K in Q3 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Pittenger & Anderson Inc held 1,050 shares of iShares Biotechnology ETF worth $200K as of Q2 2026.
Pittenger & Anderson Inc left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.01% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #234 holding.
Pittenger & Anderson Inc first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 52 quarters since.
Pittenger & Anderson Inc's iShares Biotechnology ETF position peaked at $562K in Q3 2021.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.